Exome Asset Management’s Celldex Therapeutics CLDX Stock Holding History

Exome Asset Management’s Portfolio CLDX Stock Details CLDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.49M	Buy
2024 Q2	–	Sell
2024 Q1	$2.98M	Sell
2023 Q4	$4.41M	Buy